Check patentability & draft patents in minutes with Patsnap Eureka AI!

Reagent kit for inspecting apoAI and apoB

A kit and single-reagent technology, applied in the preparation of APOB antibody, apoA I, apoB kit, anti-APOA I field, can solve the problems of low value and high value, inconvenient operation, low antiserum titer, etc., and achieve the source of immunity sex high effect

Active Publication Date: 2011-08-17
浙江伊利康生物技术有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Known methods for measuring apoA I and apoB include chromatography, electrophoresis, and immunoassay. Among them, chromatography and electrophoresis are cumbersome to operate, and they cannot perform batch sample analysis and directly go to full-automatic biochemical analyzers. The immunodiffusion method, radioimmunoassay method, fluorescent labeling immunoassay method, enzyme-labeled immunoassay method, and chemiluminescence immunoassay method also have many deficiencies. If special equipment is required, the sample needs to be pretreated, and it cannot be used on a global scale. Automatic biochemical analyzer for batch detection and analysis, etc.
The immunoturbidimetric method commonly used in clinical practice is popular because of its small amount of sample, which can be directly analyzed in batches on an automatic biochemical analyzer, and is easy to operate. However, the currently established methods and reagents have some shortcomings and / or Insufficient, mainly manifested in: First, the antibody titer is not high, all below 1:16, and the specificity, affinity, and affinity are not good; second, the calibration serum is based on human serum, although the hepatitis B surface antigen is negative, HIV detection Negative human serum with normal alanine aminotransferase, but it is difficult to rule out the possibility of no other infectious diseases, which brings great danger to the operator, and it is a freeze-dried product, and the value of each batch is different , needs to be reconstituted with water before use, the operation is extremely inconvenient, and the reconstitution of different reconstituters varies greatly between the bottles. After reconstitution, it must be frozen and stored, especially if it cannot be thawed repeatedly, which will not only cause waste of reagents, but also affect the quality. To ensure that the measurement results vary greatly, and its stability is not good; the third is that the anti-interference ability of high-fat, jaundice, and hemolysis samples is poor
Fourth, the single-point calibration solution is used for calibration, which does not conform to the calculation of the curve regression equation, resulting in the phenomenon of low high values ​​and high low values, and the measured results are inaccurate
Fifth, the antiserum precipitates in a short period of time, making it difficult to operate on the machine and affecting the detection effect
The disadvantage of the above method is that the ultracentrifugation takes a long time, and the protein is often denatured and the spatial structure of the protein is changed during the process of degreasing and ultracentrifugation, and the immunogenicity of the protein is changed, so that the antiserum effect of the immune obtained The price is not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] B. Antibody preparation

[0035] The preparation of the antibody disclosed in the present invention is divided into two parts: one is the immune process; the other is the separation of the antibody. in:

[0036] One, the method of the present invention only needs to be divided into 4 immunization processes and can be completed; the 1st time: before immunization, inject a small dose of antibiotics to the groin, abdominal cavity and back of the sheep, give and inject substances that can reduce the immune ability of the sheep after 7 days, For example, pristane, etc. After 3 days, use the mixed solution of surfactant, apoA I and apoB antigen to inject multiple points and small doses intradermally and subcutaneously on the back and both sides of the inner thigh of the sheep. The amount of apoA I and apoB antigens depends on the weight of the sheep, generally 0.5-5 mg, preferably 1-2 mg, for 50 kg of body weight. The volume ratio of antigen to surfactant is 1:1 to 1:2 (rec...

Embodiment 1 1

[0074] Embodiment 1 one, antigen extraction

[0075] 1. Mix 200ml of mixed serum with 300ml of aliphatic surfactant to form a surfactant-serum complex. 2. Slowly add 100ml of a known heparin manganese precipitant to 200ml of surfactant-mixed serum or plasma on a magnetic stirrer to precipitate lipoproteins. After collecting the precipitate, wash it 3 times with normal saline. 3. Remove lipids from lipoproteins: use the known Scanu method to degrease, that is: add the washed lipoprotein precipitates to pre-cooled (-15°C) absolute ethanol: anhydrous ether (3: 2) In the mixed solution, stir continuously, after 12 hours overnight, centrifuge (2000r / min) at -10°C (or 4°C), remove the supernatant to obtain a precipitate, and repeat the degreasing process once, 3. Degrease the above The final precipitate is electrophoresed with a known SDS-PAGE (sodium dodecyl sulfate-polyacrylamide) gel, and the two parts of the gel are separated according to the different positions of apoA I and a...

Embodiment 2

[0082] Example 2 is basically the same as Example 1, except that when the antigen-surfactant complex is injected in the first immunization, the dosage of the antigen is 2 mg according to the body weight of the 50 kg animal.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In the invention, its dual dose types comprises: a) a reactant comprising buffer solution, high molecule accelerator; b) an antibody agent comprising anti apoA I antiserum, anti apoB antiserum; and antiserum buffer solution; c) fluid serotype constant calibration liquid comprising apoA I antigen, apoB antigen. Its single dose type comprises: a) antibody liquid comprising anti apoA I antiserum, anti apoB antiserum and reactant; b) liquid serotype constant calibrate liquid comprising buffer liquid, apoA I antigen and AapoB antigen.

Description

technical field [0001] The invention relates to a preparation method of an antibody and a kit for measuring serum components, in particular to a preparation method for anti-APOA I and APOB antibodies and a kit for measuring apoA I and apoB in serum, which can be widely used in medical and biochemical technologies field. Background technique [0002] Apolipoprotein A I (apo A I) is the largest component of the apoA family. ApoA I is a single polypeptide chain consisting of 243 amino acid residues with a molecular weight of 28300D. It is the main apolipoprotein of high-density lipoprotein (HDL) . HDL has the effect of preventing atherosclerosis, therefore, measuring the content of apoA I in serum (plasma) has become a routine detection item for preventing cardiovascular and cerebrovascular diseases. Apolipoprotein B (apoB) is the main protein of low-density lipoprotein (LDL), and increased LDL is a recognized risk factor for atherosclerosis. Therefore, the determination of s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/68
Inventor 王贤理蒙凯蔡其浩
Owner 浙江伊利康生物技术有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More